Nabeel Mohammad Qassem M.D.
Internal medicine resident, Internal medicine department, Hamad medical corporation, Doha, Qatar.
Key clinical message :
Eptifibatide induced thrombocytopenia is a rare but serious side effect, which is diagnosed clinically after excluding other causes, and warrants close monitoring and observation to prevent more serious complications.
Keywords: Eptifibatide, Glycoprotien (GP) IIb/IIIa, Thrombocytopenia.
*Corresponding author:
Yazan M. Sallam, M.D.
Internal medicine resident,
Department of Internal medicine,
Hamad medical corporation,
Doha, Qatar
PO BOX 3050
yazansallam@gmail.com
+974 55176017